10 Sarker S, Ott CM, Barrila J, Nickerson CA. Discovery of spaceflight-regulated virulence mechanisms in Salmonella and other microbial pathogens: Novel approaches to commercial vaccine development. Gravit Space Biol. 2010 Aug;23(2):75-8. (PI: C.A. Nickerson) NOTE: This article, a review of C.A. Nickerson's ground and space flight research, may be obtained online without charge. Scroll to the article: http://asgsb.org/bulletins/v23n2/v23n2.pdf This issue also includes nine 2-page articles, which are not included in this list. The entire issue may be obtained online without charge at the url above.

11 Wheeler RM. Plants for human life support in space: From Myers to Mars. Gravit Space Biol. 2010 Aug;23(2):25-35. This article may be obtained online without charge. Scroll to the article: http://asgsb.org/bulletins/v23n2/v23n2.pdf

13 Uhran ML. Status of US national laboratory on the ISS. Gravit Space Biol. 2010 Aug;23(2):67-74. NOTE: This article may be obtained online without charge. Scroll to the article: http://asgsb.org/bulletins/v23n2/v23n2.pdf

Other papers of interest:

1 Zhuravleva OA, Morukov BV, Markin AA, Vostrikova LV, Zabolotskay IV. Lipid peroxidation rate and the antioxidant protection system during the readaptation period after long-term space flights on board the International Space Station. Hum Physiol. 2011 May;37(3):347-50.http://dx.doi.org/10.1134/S0362119711030170 NOTE: ISS results. This is a translation in English of the Russian original published in Fiziologiya Cheloveka 2011 May-Jun;37(3):92-7: http://www.ncbi.nlm.nih.gov/pubmed/21780685

7 Kotanen C, Guiseppi-Elie A. Development of an implantable biosensor system for physiological status monitoring during long duration space exploration. Gravit Space Biol. 2010 Aug;23(2):55-63. NOTE: This article may be obtained online without charge. Scroll to the article: http://asgsb.org/bulletins/v23n2/v23n2.pdf

22 Bikle DD, Wang Y. Insulin like growth factor-I: A critical mediator of the skeletal response to parathyroid hormone. Curr Mol Pharmacol. 2011 Jun 25. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/21787292 NOTE: This article and the next three articles are part of a "Hot Topic Issue: Molecular and Pharmacological Aspects of Existing and Experimental Bone Anabolic Therapies." The articles are listed here: http://www.benthamscience.com/cmp/E-Pub-Ahead-of-Schedule.htm An editorial summarizing the issue by N. Chattopadhyay is available without charge.

31 Bialek P, Morris CA, Parkington J, St.Andre M, Owens J, Yaworsky P, Seeherman H, Jelinsky SA. Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy. Physiol Genomics. 2011 Jul 26. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/21791639 NOTE: From abstract: "The degradation following casting was ubiquitin-proteasome-mediated, while degradation following tenotomy was lysosomal and matrix-metalloproteinase (MMP)-mediated, suggesting a possible role for autophagy. These data suggest that there are multiple mechanisms leading to muscle atrophy and that specific therapeutic agents may be necessary to combat atrophy resulting from different conditions."

32 Dobrowolny G, Aucello M, Musaro A. Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation. Skelet Muscle. 2011 Jan 24;1:3.http://www.ncbi.nlm.nih.gov/pubmed/21798081 NOTE: This is a new journal. This article may be obtained online without charge.